These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34745031)

  • 1. Quantitative PCR to Discriminate Between
    Sarasombath PT; Thongpiya J; Chulanetra M; Wijit S; Chinabut P; Ongrotchanakun J; Jitmuang A; Wanachiwanawin D
    Front Microbiol; 2021; 12():729193. PubMed ID: 34745031
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization.
    Matsumura Y; Ito Y; Iinuma Y; Yasuma K; Yamamoto M; Matsushima A; Nagao M; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2012 Jun; 18(6):591-7. PubMed ID: 21973089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients.
    Maillet M; Maubon D; Brion JP; François P; Molina L; Stahl JP; Epaulard O; Bosseray A; Pavese P
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):331-6. PubMed ID: 23990137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.
    Damiani C; Le Gal S; Da Costa C; Virmaux M; Nevez G; Totet A
    J Clin Microbiol; 2013 Oct; 51(10):3380-8. PubMed ID: 23903553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients.
    Fauchier T; Hasseine L; Gari-Toussaint M; Casanova V; Marty PM; Pomares C
    J Clin Microbiol; 2016 Jun; 54(6):1487-1495. PubMed ID: 27008872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interest of a Commercialized
    Lussac-Sorton F; Fleur T; Voisin T; Issa N; Blanchard É; Charpentier É; Delhaes L
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR.
    Szvalb AD; Malek AE; Jiang Y; Bhatti MM; Wurster S; Kontoyiannis DP
    J Infect; 2020 Sep; 81(3):443-451. PubMed ID: 32650108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii.
    Louis M; Guitard J; Jodar M; Ancelle T; Magne D; Lascols O; Hennequin C
    J Clin Microbiol; 2015 Dec; 53(12):3870-5. PubMed ID: 26468505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of quantitative PCR to discriminate
    Perret T; Kritikos A; Hauser PM; Guiver M; Coste AT; Jaton K; Lamoth F
    J Med Microbiol; 2020 May; 69(5):705-711. PubMed ID: 32369002
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients.
    Rogina P; Skvarc M
    Radiol Oncol; 2020 May; 54(2):221-226. PubMed ID: 32463392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a real-time PCR for diagnosis of Pneumocystis pneumonia in immunocompromised patients - Experience from a tertiary care center, India.
    S D; S TD; Gupta R; Varughese S; Varghese GM; George B; Michael JS
    J Mycol Med; 2022 May; 32(2):101241. PubMed ID: 34999296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.
    Hammarström H; Grankvist A; Broman I; Kondori N; Wennerås C; Gisslen M; Friman V
    BMC Infect Dis; 2019 Jul; 19(1):658. PubMed ID: 31337356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of quantitative real-time PCR and direct immunofluorescence for the detection of Pneumocystis jirovecii.
    Moodley B; Tempia S; Frean JA
    PLoS One; 2017; 12(7):e0180589. PubMed ID: 28683092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients.
    Montesinos I; Brancart F; Schepers K; Jacobs F; Denis O; Delforge ML
    Diagn Microbiol Infect Dis; 2015 Jun; 82(2):143-7. PubMed ID: 25801778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time PCR is more specific than conventional PCR for induced sputum diagnosis of Pneumocystis pneumonia in immunocompromised patients without HIV infection.
    Fujisawa T; Suda T; Matsuda H; Inui N; Nakamura Y; Sato J; Toyoshima M; Nakano Y; Yasuda K; Gemma H; Hayakawa H; Chida K
    Respirology; 2009 Mar; 14(2):203-9. PubMed ID: 19210645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low cut-off value of serum (1,3)-beta-D-glucan for the diagnosis of Pneumocystis pneumonia in non-HIV patients: a retrospective cohort study.
    Taniguchi J; Nakashima K; Matsui H; Watari T; Otsuki A; Ito H; Otsuka Y
    BMC Infect Dis; 2021 Nov; 21(1):1200. PubMed ID: 34844554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization.
    Tasaka S; Kobayashi S; Yagi K; Asami T; Namkoong H; Yamasawa W; Ishii M; Hasegawa N; Betsuyaku T
    J Infect Chemother; 2014 Nov; 20(11):678-81. PubMed ID: 25066434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.
    Huggett JF; Taylor MS; Kocjan G; Evans HE; Morris-Jones S; Gant V; Novak T; Costello AM; Zumla A; Miller RF
    Thorax; 2008 Feb; 63(2):154-9. PubMed ID: 17693588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.
    Robert-Gangneux F; Belaz S; Revest M; Tattevin P; Jouneau S; Decaux O; Chevrier S; Le Tulzo Y; Gangneux JP
    J Clin Microbiol; 2014 Sep; 52(9):3370-6. PubMed ID: 25009050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.
    Alanio A; Desoubeaux G; Sarfati C; Hamane S; Bergeron A; Azoulay E; Molina JM; Derouin F; Menotti J
    Clin Microbiol Infect; 2011 Oct; 17(10):1531-7. PubMed ID: 20946413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.